Accessibility Menu
 
Star Combo Pharma logo

Star Combo Pharma

(ASX) S66

Current Price$0.23
Market Cap$30.38M
Since IPO (2018)-70%
5 Year-6%
1 Year+83%
1 Month+18%

Star Combo Pharma Financials at a Glance

Market Cap

$30.38M

Revenue (TTM)

$53.53M

Net Income (TTM)

$6.28M

EPS (TTM)

$0.04

P/E Ratio

5.64

Dividend

$0.00

Beta (Volatility)

-0.07 (Low)

Price

$0.23

Volume

0

Open

$0.20

Previous Close

$0.23

Daily Range

$0.20 - $0.23

52-Week Range

$0.12 - $0.28

S66 News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Star Combo Pharma

Industry

Personal Products

CEO

Su Zhang, MBA

Headquarters

Smithfield, NSW 2164, AU

S66 Financials

Key Financial Metrics (TTM)

Gross Margin

23%

Operating Margin

-2%

Net Income Margin

23%

Return on Equity

15%

Return on Capital

-1%

Return on Assets

11%

Earnings Yield

17.73%

Dividend Yield

1.65%

Payout Ratio

9.28%

Stock Overview

Market Cap

$30.38M

Shares Outstanding

135.00M

Volume

0

Avg. Volume

14.13K

Financials (TTM)

Gross Profit

$6.27M

Operating Income

$237.98K

EBITDA

$6.64M

Operating Cash Flow

$11.94M

Capital Expenditure

$393.72K

Free Cash Flow

$11.55M

Cash & ST Invst.

$18.11M

Total Debt

$3.93M

Star Combo Pharma Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$11.93M

-2.5%

Gross Profit

$2.53M

-1.9%

Gross Margin

21.18%

N/A

Market Cap

$30.38M

N/A

Market Cap/Employee

$1.01M

N/A

Employees

30

N/A

Net Income

$413.24K

+228.7%

EBITDA

$553.04K

+40.2%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Net Cash

$9.89M

+94.8%

Accounts Receivable

$2.42M

-26.1%

Inventory

$3.73M

-6.0%

Long Term Debt

$8.00M

+102.3%

Short Term Debt

$290.18K

+84.9%

Return on Assets

11.46%

N/A

Return on Invested Capital

-0.94%

N/A

Free Cash Flow

$279.70K

+337.6%

Operating Cash Flow

$575.23K

+13.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MBH.AXMaggie Beer Holdings Limited
$0.08+0.62%
NOU.AXNoumi Limited
$0.10-4.55%
KME.AXKip McGrath Education Centres Limited
$0.59+1.71%
ZNO.AXZoono Group Limited
$0.07-4.41%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$13.30+0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.07+0.05%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.70+0.01%
SOFISoFi Technologies
$16.43+0.02%

Questions About S66

What is the current price of Star Combo Pharma?

Star Combo Pharma is trading at A$0.23 per share.

What is the 52-week range for Star Combo Pharma?

Over the past 52 weeks, Star Combo Pharma has traded between A$0.12 and A$0.28.

How much debt does Star Combo Pharma have?

As of the most recent reporting period, Star Combo Pharma reported total debt of $3.93M.

How much cash does Star Combo Pharma have on hand?

Star Combo Pharma reported $3.59M in cash and cash equivalents in its most recent financial results.

What is Star Combo Pharma’s dividend yield?

Star Combo Pharma currently has a dividend yield of 1.65%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.